Related Experiment Video
Updated: Dec 1, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
The Relationship Between Interleukin-4 Levels and Cardiovascular Events in Patients with Chronic Kidney Disease
Ling Gu1, Huogen Liu1, Xianhong Liu2
1Department of Critical Care Medicine, Mindong Hospital of Fujian Medical University, Fuan, Fujian 355000, People's Republic of China.
Insights
Higher serum Interleukin-4 (IL-4) levels are linked to increased cardiovascular events in chronic kidney disease (CKD) patients. This finding may aid in early CV event prediction for individuals with CKD.
Area of Science:
- Nephrology
- Cardiology
- Immunology
Background:
- Cardiovascular diseases (CVDs) are the leading cause of mortality in chronic kidney disease (CKD) patients.
- Interleukin-4 (IL-4), an inflammatory cytokine, has been minimally studied regarding its association with cardiovascular events in CKD.
- This study addresses the gap by investigating the relationship between serum IL-4 levels and cardiovascular event risk in CKD.
Purpose of the Study:
- To determine if serum IL-4 levels are associated with an increased risk of cardiovascular (CV) events in patients with CKD.
- To explore the predictive value of IL-4 for early CV event detection in CKD.
Main Methods:
- A cohort of 302 patients with stage 1-5 CKD were followed for a mean of 32 months.
- Serum IL-4 levels were measured at baseline.
- Multivariate Cox regression analysis was employed to assess the independent relationship between serum IL-4 and CV events.
Main Results:
- The study included 302 patients (65.4 years average age, 69.9% male).
- A total of 41 (13.6%) CV events occurred during follow-up.
- Higher serum IL-4 levels (above mean of 126.2 pg/mL) were associated with a significantly increased rate of CV events (HR=1.650, P<0.001), particularly in CKD stages 3-5.
- This association remained significant regardless of anti-inflammatory medication use.
Conclusions:
- Elevated serum IL-4 levels are significantly associated with a higher risk of cardiovascular events in patients with CKD.
- Serum IL-4 may serve as a valuable biomarker for predicting early cardiovascular events in the CKD population.
- Stratified analysis indicated a stronger association in advanced CKD stages (3-5).
Background:
Cardiovascular diseases (CVDs) are the main cause of death in patients with chronic kidney disease (CKD). Interleukin-4 (IL-4) is considered an inflammatory cytokine. However, few studies have investigated the association between serum IL-4 and cardiovascular events in CKD. This study investigated whether serum IL-4 levels were associated with an increased risk of cardiovascular (CV) events in patients with CKD.
Patients And Methods:
A total of 302 patients with stage 1-5 CKD were followed up for a mean of 32 (range=4-36) months for end points (CV events). Serum IL-4 levels were measured at baseline. The independent relationship between serum IL-4 and the risk of CV events was assessed with multivariate Cox regression analysis.
Results:
The average age of this cohort (N=302) was 65.4 years. A total of 69.9% of them were male. CV events numbered 41 (13.6%) during the follow-up period. The Kaplan-Meier analysis showed that the rate of CV events was higher in patients with CKD with IL-4 levels above the mean (126.2 pg/mL) than in those with IL-4 levels below the mean. The multivariate Cox proportional hazard analysis revealed that serum IL-4 (HR=1.650, 95% CI 1.266-2.210, P<0.001) was associated with CV events in these patients with CKD. Sensitivity analysis showed that the association between serum IL-4 and CV events was not affected by the use of anti-inflammatory medication. The significant association between higher IL-4 levels and increased risk of CV events existed in patients with CKD3-5 but not in patients with CKD1-2 by using the stratified analysis.
Conclusion:
Higher serum IL-4 levels were associated with an increased risk of CV events during follow-up. Elevated serum IL-4 levels may help clinicians predict early CV events in patients with CKD.
More Related Videos
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Acute Kidney Injury II: Pathophysiology

